Physician profile
Angela Nix
NPI 1356308944
$2,325.19
in general payments reported to CMS, 2019-2025
30 companies · $589 in 2025
The $589 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $111 · 2021: $154 · 2022: $101 · 2023: $309 · 2024: $205 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.55 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $451.72 | 2019-2025 | |
| Organon LLC | $350.55 | 2021-2025 | Nexplanon |
| Roche Diagnostics Corporation | $169.63 | 2019-2020 | |
| Astellas Pharma US INC | $157.87 | 2019-2025 | Veozah |
| Coopersurgical, INC. | $147.10 | 2019-2025 | Vaginal Speculum - Snowman/ Pederson Blade, Paragard T 380a, Paragard T 380a |
| Minerva Surgical, INC | $140.09 | 2019 | |
| Pfizer INC. | $84.08 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $82.99 | 2023-2025 | |
| Vertical Pharmaceuticals, LLC | $73.20 | 2019 | |
| Biogen, INC. | $54.56 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $53.41 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $50.14 | 2019-2025 | |
| Millicent US INC | $49.10 | 2025 | Intrarosa, Femring, Femlyv |
| Alydia Health | $48.96 | 2021 | |
| Therapeuticsmd, INC. | $46.34 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $42.94 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Solventum Corporation | $38.83 | 2025 | Prevena |
| Exeltis, USA INC. | $35.73 | 2024 | Slynd |
| Agile Therapeutics, INC. | $29.81 | 2023 | Twirla |
| Myovant Sciences INC. | $28.41 | 2022 | |
| Dysis Medical, INC. | $26.89 | 2023 | Dysis Ultra 2.0, Dysis V3 Digital Coploscope, Dysis View |
| Merck Sharp & Dohme LLC | $25.12 | 2019 | |
| Sage Therapeutics, LLC | $23.41 | 2019 | |
| Avion Pharmaceuticals | $23.36 | 2019 | |
| Medtronic, INC. | $18.36 | 2025 | Truclear |
| Amag Pharmaceuticals, INC. | $18.27 | 2019 | |
| Evofem Biosciences, INC. | $17.16 | 2025 | Phexxi, Solosec, Phexx |
| Aspira Women'S Health INC | $13.34 | 2024 | Ova1 |
| Lupin INC. | $12.48 | 2019 | |
| Teleflex LLC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Nix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.